Aging and aging-related diseases: from molecular mechanisms to interventions and treatments
J Guo, X Huang, L Dou, M Yan, T Shen… - Signal Transduction and …, 2022 - nature.com
Aging is a gradual and irreversible pathophysiological process. It presents with declines in
tissue and cell functions and significant increases in the risks of various aging-related …
tissue and cell functions and significant increases in the risks of various aging-related …
Osteoarthritis: pathogenic signaling pathways and therapeutic targets
Osteoarthritis (OA) is a chronic degenerative joint disorder that leads to disability and affects
more than 500 million population worldwide. OA was believed to be caused by the wearing …
more than 500 million population worldwide. OA was believed to be caused by the wearing …
Osteoarthritis: toward a comprehensive understanding of pathological mechanism
Osteoarthritis (OA) is the most common degenerative joint disease and a major cause of
pain and disability in adult individuals. The etiology of OA includes joint injury, obesity …
pain and disability in adult individuals. The etiology of OA includes joint injury, obesity …
Changes in the osteochondral unit during osteoarthritis: structure, function and cartilage–bone crosstalk
SR Goldring, MB Goldring - Nature Reviews Rheumatology, 2016 - nature.com
In diarthrodial joints, the articular cartilage, calcified cartilage, and subchondral cortical and
trabecular bone form a biocomposite—referred to as the osteochondral unit—that is …
trabecular bone form a biocomposite—referred to as the osteochondral unit—that is …
The role of matrix metalloproteinases in osteoarthritis pathogenesis: An updated review
Extensive degeneration of articular cartilage (AC) is a primary event in the pathogenesis of
osteoarthritis (OA) and other types of joint and bone inflammation. OA results in the loss of …
osteoarthritis (OA) and other types of joint and bone inflammation. OA results in the loss of …
Disease-modifying therapeutic strategies in osteoarthritis: current status and future directions
Y Cho, S Jeong, H Kim, D Kang, J Lee… - … & molecular medicine, 2021 - nature.com
Osteoarthritis (OA) is the most common form of arthritis. It is characterized by progressive
destruction of articular cartilage and the development of chronic pain and constitutes a …
destruction of articular cartilage and the development of chronic pain and constitutes a …
Mechanisms and therapeutic implications of cellular senescence in osteoarthritis
PR Coryell, BO Diekman, RF Loeser - Nature Reviews Rheumatology, 2021 - nature.com
The development of osteoarthritis (OA) correlates with a rise in the number of senescent
cells in joint tissues, and the senescence-associated secretory phenotype (SASP) has been …
cells in joint tissues, and the senescence-associated secretory phenotype (SASP) has been …
LDHA-mediated ROS generation in chondrocytes is a potential therapeutic target for osteoarthritis
The contribution of inflammation to the chronic joint disease osteoarthritis (OA) is unclear,
and this lack of clarity is detrimental to efforts to identify therapeutic targets. Here we show …
and this lack of clarity is detrimental to efforts to identify therapeutic targets. Here we show …
The role of innate immune responses and neuroinflammation in amyloid accumulation and progression of Alzheimer's disease
A Webers, MT Heneka… - Immunology and cell …, 2020 - Wiley Online Library
Alzheimer's disease (AD) is characterized by amyloid beta (Aβ) accumulation, tau pathology
and neuroinflammation. Recently, there has been considerable interest in the role of …
and neuroinflammation. Recently, there has been considerable interest in the role of …
Magnetic polysaccharide mesenchymal stem cells exosomes delivery microcarriers for synergistic therapy of osteoarthritis
Osteoarthritis (OA) is a prevalent degenerative disease that afflicts more than 250 million
people worldwide, impairing their mobility and quality of life. However, conventional drug …
people worldwide, impairing their mobility and quality of life. However, conventional drug …